Zoetis Inc (ZTS)

Zoetis Inc (ZTS) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $33.9B; returns 1 day -1.2%, 1 week +2.1%, 1 year -44.5%.

Zoetis Inc. is the world's largest pure-play animal health company, engaged in the discovery, development, manufacture, and commercialization of a diverse portfolio of medicines, vaccines, diagnostics, and technologies. The company's revenue is primarily driven by two major segments: Companion Animal products (approximately 65-67% of revenue) and Livestock products (approximately 33-35%).

Groups ZTS belongs to

• Dividend Payers
• Healthcare
• Shrinking Share Count
• Buying Back Stock
• S&P 500
• Life Sciences
• Humanization of Pets
• Pharmaceuticals
• Medical Devices
• Biotechnology
• Biologics
• Animal Nutrition
• Dermatology
• Pain Management
• Health Diagnostics and Imaging
• Agribusiness

ZTS financial model: income statement, cash flow and balance sheet